The novel mouse serine-threonine kinase protein kinase D (PKD) is activated
in intact Swiss 3T3 cells stimulated by phorbol esters, cell permeant diac
ylglycerols, bryostatin, neuropeptides and growth factors via a phosphoryla
tion-dependent mechanism requiring protein kinase C (PKC) activity. Structu
ral comparison of the PKD catalytic domain with other kinases reveals a clo
se similarity with MEK family kinases, which are activated upon phosphoryla
tion of key serine and threonine residues in a region termed the activation
loop. To study the regulation of PKD, we transfected mutant PKD cDNAs in w
hich putative activation loop serine residues 744 and 748 were mutated to e
ither alanine or glutamic acid into COS-7 cells. Replacement of serines 744
and 748 with alanine prevented activation of the overexpressed PKD form up
on phorbol ester treatment of cells, whereas replacement with glutamic acid
results in full constitutive activation. Single serine to glutamic acid re
placement mutants were partially activated. In vivo P-32-labeling and two-d
imensional phosphopeptide mapping of PKD and catalytically inactive PKD mut
ants at serine 744, 748 or at both residues revealed that phorbol ester-sen
sitive phosphopeptides could be selectively eliminated from patterns observ
ed as a result of these mutations. Treatment of cells with the PKC inhibito
r GFI also prevented the appearance of phosphopeptide spots occuring in res
ponse to phorbol ester stimulation. These results provide direct evidence t
hat PKD becomes activated in vivo as a consequence of PKC-mediated phosphor
ylation of serines 744 and 748. These results support our view of PKD as an
important clement in PKC signal transduction.